Cargando…
p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation.
Forty-two patients with hepatocellular carcinoma (HCC) were resected and their tumours were analysed for p53 mutations by GC-clamped denaturing gradient gel electrophoresis (DGGE), single-strand conformation polymorphism (SSCP) and gene sequencing. All the exons have been analysed in this study. Eig...
Autores principales: | Honda, K., Sbisà , E., Tullo, A., Papeo, P. A., Saccone, C., Poole, S., Pignatelli, M., Mitry, R. R., Ding, S., Isla, A., Davies, A., Habib, N. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149958/ https://www.ncbi.nlm.nih.gov/pubmed/9514057 |
Ejemplares similares
-
Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer?
por: Valletti, Alessio, et al.
Publicado: (2019) -
TRIM8: Making the Right Decision between the Oncogene and Tumour Suppressor Role
por: Caratozzolo, Mariano Francesco, et al.
Publicado: (2017) -
TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours
por: Mastropasqua, Francesca, et al.
Publicado: (2017) -
The Underestimated Role of the p53 Pathway in Renal Cancer
por: Amendolare, Alessandra, et al.
Publicado: (2022) -
p53FamTaG: a database resource of human p53, p63 and p73 direct target genes combining in silico prediction and microarray data
por: Sbisà, Elisabetta, et al.
Publicado: (2007)